The products of metabolism of unsaturated fatty acids by oxygenases (prostaglandins, leukotrienes, and HETEs, Hydroxyeicosatetraenoic acids) are well established as important signaling molecules and mediators. Based on these precedents, the occurrence of a peculiar hydroxy fatty acid metabolite, 12R- HETE, in human epidermis, and particularly its prominence in proliferative skin diseases exemplified by psoriasis, is strongly suggestive of its significance to the pathophysiology of skin. Although 12R-HETE was usually considered a product of cytochrome P450, recently we established that a lipoxygenase is the enzyme type responsible for 12R-HETE synthesis in psoriasis. From human keratinocytes we have also cloned and expressed a 12R- lipoxygenase that can account for 12R-HETE overproduction in proliferative skin disease. In this project we will examine the role of this newly discovered enzyme by: 1. Characterization of the human 12R-lipoxygenase and its catalytic activities. 2. Establishing the tissue and cellular localization of the enzyme, including in psoriasis and other proliferative and inflammatory skin disease. 3. We will assess 12R-Lox expression in established mouse models of skin disease, and 4. Develop and characterize transgenic animals overexpressing the human 12R-lipoxygenase with targeted expression to epidermis. These studies will elucidate the sites and regulation of 12R-HETE synthesis, assess its biosynthesis in normal and diseased tissues, elucidate the effects of 12R-HETE overexpression in animal models, and will prepare the way for a rational appraisal of lipoxygenase inhibitors as a potential therapy in proliferative skin disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR045943-03
Application #
6375198
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Moshell, Alan N
Project Start
1999-09-30
Project End
2003-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$260,901
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Yu, Zheyong; Schneider, Claus; Boeglin, William E et al. (2005) Mutations associated with a congenital form of ichthyosis (NCIE) inactivate the epidermal lipoxygenases 12R-LOX and eLOX3. Biochim Biophys Acta 1686 3:238-47
Melner, Michael H; Ducharme, Nicole A; Brash, Alan R et al. (2004) Differential expression of genes in the endometrium at implantation: upregulation of a novel member of the E2 class of ubiquitin-conjugating enzymes. Biol Reprod 70:406-14
Schneider, Claus; Strayhorn, W David; Brantley, Dana M et al. (2004) Upregulation of 8-lipoxygenase in the dermatitis of IkappaB-alpha-deficient mice. J Invest Dermatol 122:691-8
Yu, Zheyong; Schneider, Claus; Boeglin, William E et al. (2003) The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hydroperoxide isomerase. Proc Natl Acad Sci U S A 100:9162-7
Schneider, Claus; Brash, Alan R (2002) Lipoxygenase-catalyzed formation of R-configuration hydroperoxides. Prostaglandins Other Lipid Mediat 68-69:291-301
Schneider, C; Keeney, D S; Boeglin, W E et al. (2001) Detection and cellular localization of 12R-lipoxygenase in human tonsils. Arch Biochem Biophys 386:268-74
Brash, A R (2001) Arachidonic acid as a bioactive molecule. J Clin Invest 107:1339-45